| Product Code: ETC6751624 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Primary Biliary Cholangitis Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Primary Biliary Cholangitis Market Revenues & Volume, 2021 & 2031F |
3.3 China Primary Biliary Cholangitis Market - Industry Life Cycle |
3.4 China Primary Biliary Cholangitis Market - Porter's Five Forces |
3.5 China Primary Biliary Cholangitis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 China Primary Biliary Cholangitis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 China Primary Biliary Cholangitis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 China Primary Biliary Cholangitis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 China Primary Biliary Cholangitis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Primary Biliary Cholangitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of primary biliary cholangitis (PBC) in China |
4.2.2 Growing healthcare infrastructure and access to advanced treatment options |
4.2.3 Rising focus on research and development for innovative therapies in the field of liver diseases |
4.3 Market Restraints |
4.3.1 Limited availability and access to specialized healthcare facilities for PBC treatment in certain regions of China |
4.3.2 Challenges related to high treatment costs and affordability for patients |
4.3.3 Regulatory hurdles and delays in the approval process for new PBC therapies in China |
5 China Primary Biliary Cholangitis Market Trends |
6 China Primary Biliary Cholangitis Market, By Types |
6.1 China Primary Biliary Cholangitis Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 China Primary Biliary Cholangitis Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 China Primary Biliary Cholangitis Market Revenues & Volume, By Liver Transplantation, 2021- 2031F |
6.1.4 China Primary Biliary Cholangitis Market Revenues & Volume, By Drug Therapy, 2021- 2031F |
6.1.5 China Primary Biliary Cholangitis Market Revenues & Volume, By Ursodeoxycholic acid (UDCA), 2021- 2031F |
6.1.6 China Primary Biliary Cholangitis Market Revenues & Volume, By Obeticholic acid, 2021- 2031F |
6.1.7 China Primary Biliary Cholangitis Market Revenues & Volume, By Fibrates, 2021- 2031F |
6.1.8 China Primary Biliary Cholangitis Market Revenues & Volume, By Budesonide, 2021- 2031F |
6.2 China Primary Biliary Cholangitis Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 China Primary Biliary Cholangitis Market Revenues & Volume, By FibroScan, 2021- 2031F |
6.2.3 China Primary Biliary Cholangitis Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.2.4 China Primary Biliary Cholangitis Market Revenues & Volume, By Cholesterol Test, 2021- 2031F |
6.2.5 China Primary Biliary Cholangitis Market Revenues & Volume, By Antibody Test, 2021- 2031F |
6.2.6 China Primary Biliary Cholangitis Market Revenues & Volume, By Liver Test, 2021- 2031F |
6.2.7 China Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Primary Biliary Cholangitis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 China Primary Biliary Cholangitis Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 China Primary Biliary Cholangitis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 China Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Primary Biliary Cholangitis Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 China Primary Biliary Cholangitis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Primary Biliary Cholangitis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 China Primary Biliary Cholangitis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 China Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Primary Biliary Cholangitis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Primary Biliary Cholangitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 China Primary Biliary Cholangitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 China Primary Biliary Cholangitis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 China Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
7 China Primary Biliary Cholangitis Market Import-Export Trade Statistics |
7.1 China Primary Biliary Cholangitis Market Export to Major Countries |
7.2 China Primary Biliary Cholangitis Market Imports from Major Countries |
8 China Primary Biliary Cholangitis Market Key Performance Indicators |
8.1 Number of newly diagnosed PBC cases in China |
8.2 Adoption rate of advanced treatment options for PBC |
8.3 Number of clinical trials and research studies focused on PBC in China |
9 China Primary Biliary Cholangitis Market - Opportunity Assessment |
9.1 China Primary Biliary Cholangitis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 China Primary Biliary Cholangitis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 China Primary Biliary Cholangitis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 China Primary Biliary Cholangitis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 China Primary Biliary Cholangitis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Primary Biliary Cholangitis Market - Competitive Landscape |
10.1 China Primary Biliary Cholangitis Market Revenue Share, By Companies, 2024 |
10.2 China Primary Biliary Cholangitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here